Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen

Vaccine

Volumn 14, Issue 6, 1996, Pages 545-552

  Londoño, L Patricia ^a   Chatfield, Steven ^a   Tindle, Robert W ^b   Herd, Karen ^b   Gao , Xiao Ming ^a   Frazer, Ian ^b   Dougan, Gordon ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Hepatitis B; Papilloma; Salmonella; Virus core antigen

Indexed keywords

CANCER VACCINE; EPITOPE; HEPATITIS B CORE ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIVE VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOGENICITY; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PAPILLOMA VIRUS; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

EID: 0030009053     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00216-N     Document Type: Article

References (43)

1. Kaur, P., McDougall, J.K. and Cone, R. Immortalisation of primary human epithelial cells by cloned cervical carcinoma DNA containing human papillomavirus type 16 E6/E7 open reading frames. J. Gen. Virol. 1989, 70, 1261-1266
2. Labeit, D., Back, W., Weizsacker, F.V., Hermann, P., Melchert, F., Leonard, K. and Labeit, S. Increased detection of HPV 16 virus in invasive, but not in early cervical cancers. J. Virol. 1992, 63, 1549-1557
3. Matlashewski, G., Schneider, J., Banks, L., Jones, N., Murray, A. and Crawford, L. Human papillomavirus 16 DNA cooperates with activated ras in transforming primary cells. EMBO J. 1989, 6, 1741-1746
4. Bedell, M.A., Jones, K.H., Grossman, S.R. and Laimins, L.A. Identification of human papillomavirus type 18 transforming genes in immortalised and primary cell. J. Virol. 1989, 63, 1247-1255
5. Pirisi, L., Yasumoto, M., Feller, M., Doniger, J. and Paolo, J.A.D. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol. 1987, 61, 1061-1066
6. Barbosa, M.S. and Schelegel, R. The E7 and E6 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 1989, 4, 1529-1532
7. Smotkin, D. and Wettstein, F.O. The major human papillomavirus protein in cervical cancer is a cytoplasmatic phosphoprotein. J. Virol. 1987, 61, 1686-1689
8. Greenfield, I., Nickerson, J., Penman, S. and Stanley, M. Human papillomavirus 16 E7 protein is associated with the nuclear matrix. Proc. Natl Acad. Sci. USA 1991, 88, 11217-11221
9. Munger, K., Werness, B.A., Dyson, N., Phelps, W.C., Harlow, E. and Howley, P.M. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor supressor gene product. EMBO J. 1989, 8, 4099-4105
10. Jochmus-Kudielka, I., Schneider, A., Braun, R., Kimming, R., Koldovsky, U., Schneweis, K.E., Seedorf, K. and Gissman, L. Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J. Natl Cancer Inst. 1989, 81, 1698-1704
11. Mann, V.M., Loo de Lao, S., Brenes, M.A.B.L., Rawls, J.A., Green, M., Reeves, W.C. and Rawls, W.E. Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. Cancer Res. 1990, 50, 7815-7819
12. Comerford, S., McCance, D.J., Dougan, G. and Tite, J.P. Identification of T- and B-epitopes of the E7 protein of Human Papillomavirus type 16. J. Virol. 1991, 65, 4681-4690
13. Tindle, R.W., Smith, J.A., Geysen, H.M., Selvey, L.A. and Frazer, I.H. Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein. J. Gen. Virol. 1990, 71, 1347-1354
14. Tindle, R.W., Fernando, G.J., Sterling, J.C. and Frazer, I.H.A. "Public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proc. Natl Acad. Sci. USA 1991, 88, 5887-5891
15. Shepherd, P.S., Tran, T.T.T., Rowe, A.J., Cridland, J.C., Comerford, S., Chapman, M.G. and Rayfield, L.S. T cell responses to the human papillomavirus type 16 E7 protein in mice of different haplotypes. J. Gen. Virol. 1992, 73, 1269-1274
16. Feltkamp, M.C., Smits, H.L., Vierboom, M.P., Minnaar, R.P., de, J.B., Drijfhout, J.W., ter, S.J., Melief, C.J. and Kast, W.M. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 1993, 23, 2242-2249
17. Chen, L.P., Thomas, E.K., Hu, S.L., Hellstrom, I. and Hellstrom, K.E. Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc. Natl Acad. Sci. USA 1991, 88, 110-114
18. Dougan, G. 1993 Colworth Prize Lecture. The molecular basis for the virulence of bacterial pathogens: implications for oral vaccine development. Microbiology 1994, 140, 215-224
19. Maskell, D.J., Sweeney, K.J., O'Callaghan, D., Hormaeche, C.E., Liew, F.Y. and Dougan, G. Attenuated salmonellae as vaccines and carriers of foreign antigens. Microb. Pathog. 1987, 2, 211-221
20. Tindle, R.W., Herd, K., Londono, P., Fernando, G.J., Chatfield, S.N., Malcolm, K. and Dougan, G. Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice. Virology 1994, 200, 547-557
21. Francis, M.J. Use of hepatatis B core as a vehicle for presenting viral antigens. Rev. Med. Virol. 1992, 2, 225-232
22. Argos, P. and Fuller, S.D. A model for the hepatitis B core protein: prediction of antigenic sites and relationship to RNA virus capsid proteins. EMBO J. 1988, 7, 819-824
23. Brown, A.L., Francis, M.J. et al. Foreign epitopes in immunodominant regions of hepatitis B core particles are higly immunogenic and conformationally restricted. Vaccine 1991, 9, 595-601
24. Sambrook, J., Fritsch, E.F. and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbour Laboratory Press, New York, 1989.
25. Bullas, L.R. and Ryu, J.I. Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heatlabile Escherichia coli enterotoxin. J. Bacteriol. 1983, 156, 471-474
26. Strugnell, R., Dougan, G., Chatfield, S., Charles, I., Fairweather, N., Tite, J., Li, J.L., Beesley, J. and Roberts, M. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect. Immun. 1992, 60, 3994-4002
27. Chatfield, S.N., Charles, I.G., Makoff, A.J., Oxer, M.D., Dougan, G., Pickard, D., Slater, D. and Fairweather, N.F. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology 1992, 10, 888-892
28. Oxer, M.D., Bently, C.M., Doyle, J.G., Peakman, T.C., Charles, I.G. and Makoff, A.J. High level heterologous expression in E. coli using the anaerobically activated nirB promoter. Nucl. Acids Res. 1991, 19, 1889-1892
29. Elson, C.O., Ealding, W. and Lefkowitz, J. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J. Immunol. Meth. 1984, 67, 101-108
30. Clarke, B.E., Brown, A.L., Grace, K.G. et al. Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B core particles produced in bacteria. J. Gen. Virol. 1990, 71, 1109-1117
31. Menge, A.C., Michalek, S.M., Rusell, M.W. and Mestecky, J. Immune response of the female rat genital tract after oral and local immunisation with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit. Infect. Immun. 1993, 61, 2162-2171
32. O'Callaghan, D., Maskell, D., Tite, J. and Dougan, G. Immune responses in BALB/c mice following immunization with aromatic compound or purine-dependent Salmonella typhimurium strains. Immunology 1990, 69, 184-189
33. Everest, P., Frankel, G., Li, J., Lund, P., Chatfield, S. and Dougan, G. Expression of lacZ from the htrA, nirB and groE promoters in a Salmonella vaccine strain: influence on growth inside mammalian cells. FEMS Microbiol. Letters 1995, 126, 97-102
34. Schodel, R, Milich, D.R. and Will, H. Hepatitis B virus nucleocapsid/pre-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination. J. Immunol. 1990, 145, 4317-4321
35. Schodel, F., Kelly, S.M., Peterson, D.L., Milich, D.R. and Curtiss, R. 3. Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect. Immun. 1994, 62, 1669-1676
36. Thatte, J., Rath, S. and Bal, V. Immunization with live versus killed Salmonella typhimurium leads to the generation of an IFN-gamma-dominant versus an IL-4-dominant immune response. Int. Immunol. 1993, 5, 1431-1436
37. Milich, D.R., McLachlan, A., Moriarty, A. and Thorton, G.B. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg. J. Immunol. 1987, 139, 1223-1231
38. McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10, 75-88
39. Stabel, T.J., Mayfield, J.E., Tabatabai, L.B. and Wannemuehler, M.J. Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus. Infect. Immun. 1990, 58, 2048-2055
40. Stabel, T.J., Mayfield, J.E., Tabatabai, L.B. and Wannemuehler, M.J. Swine immunity to an attenuated Salmonella typhimurium mutant containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus. Infect. Immun. 1991, 59, 2941-2947
41. Brett, S.J., Gao, X.M., Liew, F.Y. and Tite, J.P. Selection of the same major T cell determinants of influenza nucleoprotein after vaccination or exposure to infectious virus. J. Immunol. 1991, 147, 1647-1652
42. Pfeifer, J.D., Wick, M.J., Roberts, R.L., Findlay, K., Normark, S.J. and Harding, C.V. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993, 361, 359-361
43. Tacket, C.O., Hone, D.M., Curtiss, R.I., Kelly, S.M., Losonsky, G., Guers, L., Harris, A.M., Edelman, R. and Levine, M.M. Comparison of the safety and immunogenicity of delta aroC, delta aroA and delta cya, delta crp Salmonella typhi strains in adult volunteers. Infect. Immun. 1992, 60, 536-544